DDD-Diagnostic A/S
A/SBankruptAdvertising protectionCVR 11296645Kærvej 12, 2970 HørsholmManufacture of irradiation, electromedical and electrotherapeutic equipment· NACE 2660Est. 1987 · 39 years old27 employees
Loading company…
Overview
DDD-Diagnostic A/S is a Danish A/S based in Hørsholm, operating in the Manufacture of irradiation, electromedical and electrotherapeutic equipment sector. Incorporated in 1987, the company has 27 employees and reported a gross profit of DKK 11.3m in its latest annual filing.
Gross profit 2021
11.3M DKK
+85% vs 2020
EBITDA margin (of gross profit)
−82.1 %
+37% vs 2020
Net profit 2021
-13.7M DKK
+27% vs 2020
Key ratios
See full ratios →Solidity ratioEquity ÷ Total assets × 100
-16.2 %
Very weakAmong the 20% lowest rated companies in the industry
20172021
Liquidity ratioCurrent assets ÷ Short-term debt
1.3×
WeakAmong the 40% lowest rated companies in the industry
20172021
Return on assets (ROA)Net profit ÷ Total assets × 100
-27.4 %
Very weakAmong the 20% lowest rated companies in the industry
20172021
EBITDA — year on year
DKK millionsKey figures
Annual report 2021| Gross profit | 11.3M DKK | +85% |
| EBITDA | -9.3M DKK | +37% |
| Net profit | -13.7M DKK | +27% |
| Total assets | 50M DKK | -2% |
| Equity | -8.1M DKK | -246% |
| Employees | 27 | — |
Company information
Legal name
DDD-DIAGNOSTIC A/S
CVR number
11296645
Legal form
Aktieselskab
Founded
18 September 1987 · 39 years
Share capital
DKK 43,070,066
Employees
27 (FTE)
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af én direktør og bestyrelsesformanden i forening, af én direktør og bestyrelsens næstformand i forening, af to bestyrelsesmedlemmer i forening eller af den samlede bestyrelse.
Contact
Address
Kærvej 12, 2970 Hørsholm
Advertising protection
Active — opted out of marketing use
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Financial development
In its most recent annual report (2021), DDD-Diagnostic A/S reported a gross profit of DKK 11.3m, an increase of 85% on the year before. The figures on this page draw on 5 annual filings covering 2017 to 2021. The bottom line showed a net loss of DKK 13.7m, and the EBITDA margin stood at -82.1%.
At the end of 2021, current assets covered short-term debt 1.3 times.
Financials
Gross profit
DKK millionsEBITDA
DKK millionsIncome statement
DKK thousands| Item | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|
| Gross profit | 11,320 | 6,134 | 390 | 2,318 | 13,215 |
| Staff expenses | -20,608 | -20,841 | -18,802 | -13,280 | -12,507 |
| EBITDA | -9,288 | -14,706 | -18,412 | -10,962 | 708 |
| Depreciation & amort. | -2,776 | -2,200 | -2,591 | -2,218 | -17,022 |
| EBIT | -12,064 | -16,907 | -21,003 | -13,180 | -16,314 |
| Net financials | -1,623 | -2,151 | -2,726 | -1,190 | -1,376 |
| Profit before tax | -13,687 | -19,058 | -23,729 | -14,370 | -17,690 |
| Tax | -0 | -235 | -2,009 | -1,786 | -3,553 |
| Net profit | -13,687 | -18,823 | -21,721 | -12,584 | -14,137 |
Get a credit rating – not just the numbers
Financial statements show the past. Risika gives you a score and a recommended credit limit, so you know what the numbers mean for your risk.
Balance sheet
DKK thousands| Item | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|
| Total assets | 50,038 | 50,859 | 50,261 | 38,431 | 32,624 |
| Equity | -8,115 | 5,572 | -9,934 | -18,038 | -12,905 |
| Long-term debt | 26,329 | 12,408 | 38,985 | 44,513 | 0 |
| Short-term debt | 31,824 | 32,879 | 21,210 | 11,956 | 45,530 |
| Total debt | 58,152 | 45,287 | 60,195 | 56,469 | 45,530 |
Financial ratios
5-year trendEBITDA margin (of gross profit)
-82.1 %
20172021
Equity ratio
-16.2 %
Very weakAmong the 20% lowest rated companies in the industry
20172021
Return on equity
—
20172021
Net profit margin (of gross profit)
-120.9 %
20172021
Asset turnover (of gross profit)
0.23×
20172021
Debt / equity
—
20172021
Sector performance
18 of 28 ratios graded28 financial ratios from the latest filing, each graded against companies in the same industry.
Profitability
Return on assets (ROA)Very weak
Among the 20% lowest rated companies in the industry
Net profit as a percentage of total assets — the return generated on the capital employed.
Basic earning power (BEP)Very weak
Among the 20% lowest rated companies in the industry
EBIT relative to total assets — the company's earning power before the effects of tax and financial leverage.
Capacity ratioVery weak
Among the 20% lowest rated companies in the industry
Shows how strongly fixed costs weigh on the gross result — a high ratio means fixed costs take only a small bite out of the earnings from basic operations.
Gross marginNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
The gross result as a share of revenue — how much of the revenue is left after variable costs to cover the company's fixed costs.
Operating marginNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
EBIT as a share of revenue — the share of revenue remaining as earnings once all operating costs are covered. A key measure of earning power.
Net profit marginNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
The profit for the year as a share of revenue — the company's ability to turn revenue into profit.
Return on equity (ROE)Not rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Net profit as a percentage of equity — the return the owners earned on their invested capital this year.
Return on net assets (RONA)Not rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Profit relative to net assets (total assets minus total debt) — the ability to generate earnings from the net asset base alone.
Liquidity
Current ratioWeak
Among the 40% lowest rated companies in the industry
Current assets relative to short-term debt — the ability to settle short-term obligations with current assets alone. Around 150% is considered satisfactory from a credit perspective.
Quick ratioVery weak
Among the 20% lowest rated companies in the industry
Current assets excluding inventory relative to short-term debt — whether the most liquid assets alone can cover the short-term obligations. A value of 1 or above signals a healthy liquidity position.
Cash ratioWeak
Among the 40% lowest rated companies in the industry
Cash relative to short-term debt — the ability to repay short-term obligations with cash alone.
Fixed assets to long-term capitalWeak
Among the 40% lowest rated companies in the industry
Fixed assets relative to long-term capital (equity plus long-term liabilities). Below 100% means the long-term capital finances more than just the fixed assets — a healthier liquidity position.
Cash conversion ratioVery weak
Among the 20% lowest rated companies in the industry
Cash flow relative to profit — the ability to convert reported profits into accessible cash.
Current assets to equityNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Current assets relative to equity — an indicator of the balance-sheet structure and of the company's short- and long-term financing. The healthy level is highly industry-dependent.
Debt & solvency
Solidity ratioVery weak
Among the 20% lowest rated companies in the industry
Equity as a share of total assets — the ability to absorb losses. Around 40% is considered satisfactory from a credit perspective.
Debt ratioVery weak
Among the 20% lowest rated companies in the industry
Total debt relative to the balance-sheet total — the share of the assets financed by debt rather than equity.
Income to debtVery weak
Among the 20% lowest rated companies in the industry
Profit relative to debt — the ability to create earnings while operating with debt.
EBITDA to debtVery weak
Among the 20% lowest rated companies in the industry
EBITDA relative to debt — how much operating earnings are available to service the debt.
Interest coverageVery weak
Among the 20% lowest rated companies in the industry
The ability to pay the interest on the company's debt out of its earnings.
Interest rate on debtWeak
Among the 40% lowest rated companies in the industry
Financial expenses relative to total liabilities — the effective interest rate the company pays on its debt.
Interest marginVery weak
Among the 20% lowest rated companies in the industry
The return on assets minus the interest rate on debt. Positive means the company benefits from operating with debt; negative means the debt makes it worse off.
Debt to equityNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Debt relative to equity — the company's leverage. A higher value means heavier reliance on debt financing.
Liabilities to equityNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Total liabilities relative to equity — whether the company operates primarily on borrowed capital or on its own.
Efficiency & development
Equity to contributed capitalVery weak
Among the 20% lowest rated companies in the industry
Total equity relative to the capital the owners contributed — how the equity has developed from its starting point.
One-year change in equityVery weak
Among the 10% lowest rated companies in the industry
The size of this year's increase or decrease in the company's equity.
One-year change in debtWeak
Among the 30% lowest rated companies in the industry
The size of this year's increase or decrease in the company's debt.
Asset turnoverNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Revenue relative to total assets — the ability to generate revenue from the asset base.
Inventory turnoverNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Revenue relative to inventory — how many times a year the inventory is sold and replaced. A low value can indicate weak sales or excess inventory.
Annual reports & filings
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
People & ownership
Management
Actively employed in the business| Name | Role | Member since |
|---|
Former (8)
JR Management | Management | 2005 – 2009 |
CH Founder | Founder | 1987 – 2025 |
MG Management | Management | 2015 – 2023 |
JM Management | Management | 1996 – 2005 |
KL Management | Management | 1987 – 1993 |
GT Management | Management | 1987 – 2000 |
CT Founder | Founder | 1987 – 2025 |
LT Management | Management | 2009 – 2015 |
Board of directors
Non-executive oversight| Name | Role | Member since |
|---|
Former (34)
SC Board of Directors | Board of Directors | 2012 – 2013 |
IP Deputy Chairman | Deputy Chairman | 2019 – 2023 |
UB Chairman | Chairman | 2013 – 2018 |
AW Chairman | Chairman | 2007 – 2010 |
FB Board of Directors | Board of Directors | 2005 – 2007 |
ET Chairman | Chairman | 2018 – 2021 |
HK Board of Directors | Board of Directors | 1987 – 1999 |
MA Board of Directors | Board of Directors | 2013 – 2016 |
JR Board of Directors | Board of Directors | 2007 – 2009 |
AD Board of Directors | Board of Directors | 2018 – 2023 |
AA Board of Directors | Board of Directors | 2015 – 2018 |
HH Board of Directors | Board of Directors | 2004 – 2004 |
LB Board of Directors | Board of Directors | 2011 – 2013 |
CH Board of Directors | Board of Directors | 1987 – 2000 |
EK Board of Directors | Board of Directors | 2016 – 2018 |
MG Board of Directors | Board of Directors | 2013 – 2017 |
SH Board of Directors | Board of Directors | 2002 – 2004 |
DH Chairman | Chairman | 2011 – 2011 |
JM Board of Directors | Board of Directors | 1996 – 2000 |
JS Chairman | Chairman | 2004 – 2007 |
PA Deputy Chairman | Deputy Chairman | 2004 – 2007 |
AK Chairman | Chairman | 2000 – 2004 |
AL Board of Directors | Board of Directors | 2007 – 2011 |
AI Chairman | Chairman | 2010 – 2011 |
LD Board of Directors | Board of Directors | 2007 – 2008 |
KL Board of Directors | Board of Directors | 2000 – 2010 |
GT Board of Directors | Board of Directors | 2007 – 2007 |
JE Board of Directors | Board of Directors | 2011 – 2013 |
CA Board of Directors | Board of Directors | 2013 – 2014 |
CT Board of Directors | Board of Directors | 1987 – 1994 |
AA Board of Directors | Board of Directors | 2008 – 2011 |
LT Board of Directors | Board of Directors | 2014 – 2015 |
JA Chairman | Chairman | 2007 – 2007 |
ET Chairman | Chairman | 2021 – 2023 |
Shareholders
Active legal owners| Shareholder | Type | Ownership | Votes | Registered |
|---|---|---|---|---|
VARINAK EUROPE SRL | Company | 100% | 100% | 2018 |
SC Vital Healthcare SRL | Company | 15–19.99% | 15–19.99% | 2019 |
Strongbow Technology Europe Limited | Company | 90–99.99% | 90–99.99% | 2019 |
| Individual | 50–66.65% | 50–66.65% | 2016 | |
Diagno Medical Systems Limited | Company | 5–9.99% | 5–9.99% | 2018 |
RusSing Development Limited | Company | 66.67–89.99% | 66.67–89.99% | 2019 |
| Individual | 100% | 100% | 2014 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
One in three Danish companies experiences fraud
Sound familiar? See how to strengthen your defences and catch suspicious changes in ownership and management in time.
Related companies
Company hierarchy
Varinak Europe SRL100%SC Vital Healthcare SRL15%Strongbow Technology Europe Limited90%Diagno Medical Systems Limited5%RusSing Development Limited66.67%
DDD-Diagnostic A/S (this company)Board network connections
Board members of DDD-Diagnostic A/S also hold positions in 222 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Dan Højgaard Jensen | Chairman | 75 companiesMany roles |
| Per Asmund Christensen | Deputy Chairman | 37 companiesMany roles |
| Lars Buhl | Board of Directors | 18 companiesMany roles |
| Jesper Ahlmann Funding Andersen | Chairman | 18 companiesMany roles |
| Claus Henrik Christiansen | Founder | 17 companiesMany roles |
| Flemming Bent Lindeløv | Board of Directors | 16 companiesMany roles |
| Arne Knudsen | Chairman | 12 companiesMany roles |
| Christel Arpalice Piron | Board of Directors | 12 companiesMany roles |
| Henning Kruse Petersen | Board of Directors | 5 companies |
| Lars Trolle | Management | 4 companies |
| Jesper Roested | Management | 2 companies |
| Michael Gustav Brock | Management | 2 companies |
| John Mountjoy Arnberg | Management | 2 companies |
| Gert Toftkjær | Management | 1 company |
| Henrik Hostrup Folkersen | Board of Directors | 1 company |
Frequently asked questions
What is the CVR number of DDD-Diagnostic A/S?
DDD-Diagnostic A/S is registered with CVR / Virk under CVR 11296645.
What is the gross profit of DDD-Diagnostic A/S?
DDD-Diagnostic A/S reported a gross profit of DKK 11.3m in 2021.
How many employees does DDD-Diagnostic A/S have?
DDD-Diagnostic A/S employs 27 people as of the latest annual report.
Where is DDD-Diagnostic A/S headquartered?
DDD-Diagnostic A/S's registered address is Kærvej 12.